Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Bicycle Therapeutics (BCYC) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Bicycle Therapeutics (BCYC) recorded Return on Capital Employed [ROCE] of -36.14% in Q2 2026, up 0.79 percentage points from -36.93% a year earlier and up 1.95 percentage points from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Bicycle Therapeutics reported Return on Capital Employed [ROCE] of -31.66%, down 2.06 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +14.50 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -29.61% in FY2024 (+14.22 pp), -43.82% in FY2023 (-14.05 pp), -29.77% in FY2022 (-6.68 pp) and -23.09% in FY2021 (+23.08 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -39.79% in Q3 2025 to -17.73% in Q1 2022 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -2.59 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 17.41 percentage points in Q4 2021, against a drop of 19.56 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -38.10% (Q1 2026), -36.13% (Q4 2025) and -39.79% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Bicycle Therapeutics 258.27 Mn -1.91 Bn - -29.17%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -29.17%
Jun 30, 2026 -36.14%
Mar 31, 2026 -38.10%
Dec 31, 2025 -36.13%
Sep 30, 2025 -39.79%
Jun 30, 2025 -36.93%
Mar 31, 2025 -28.79%
Dec 31, 2024 -23.07%
Sep 30, 2024 -20.24%
Jun 30, 2024 -25.03%
Mar 31, 2024 -34.47%
Dec 31, 2023 -34.69%
Sep 30, 2023 -35.23%
Jun 30, 2023 -39.78%
Mar 31, 2023 -35.74%
Dec 31, 2022 -32.36%
Sep 30, 2022 -26.29%
Jun 30, 2022 -21.16%
Mar 31, 2022 -17.73%
Dec 31, 2021 -19.06%
API Access

Bicycle Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BCYC&period=max&api_key=YOUR_API_KEY